Cost-Effectiveness of the U.S. FDA Added Sugar Labeling Policy for Improving Diet and Health

BACKGROUND. Excess added sugars, particularly from sugar-sweetened beverages, are a major risk factor for cardiometabolic diseases including cardiovascular disease (CVD) and type 2 diabetes. In 2016, FDA mandated the labeling of added sugar content on all packaged foods and beverages. Yet, potential...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circulation
Autors principals: Huang, Yue, Kypridemos, Chris, Liu, Junxiu, Lee, Yujin, Pearson-Stuttard, Jonathan, Collins, Brendan, Bandosz, Piotr, Capewell, Simon, Whitsel, Laurie, Wilde, Parke, Mozaffarian, Dariush, O’Flaherty, Martin, Micha, Renata
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546520/
https://ncbi.nlm.nih.gov/pubmed/30982338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.118.036751
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars